Property Report
E Experimentally determined
S Predicted by sequence similarity
P Predicted by analysis other than seq. similarity
K Predicted by BioKnowledgeTM Transfer by BIOBASE
see Indicates references that mention and cite a finding, but do not demonstrate it directly.
Colorectal Neoplasms | Prostatic Neoplasms
Human BRCA1 Negative associations for BRCA1
Gene/Protein Molecule Alteration Relationship Sub-type / Linked
disorders
Biological Process Disease Tissue Specificity Annotation & Reference
BRCA1   DNA   gene mutation   does not correlate with   Disease Susceptibility     Colorectal Neoplasms     mutation in the BRCA1 gene does not correlate with increased occurrence of disease susceptibility associated with colorectal neoplasms    [2], E  
BRCA1   DNA   gene insertion mutation   may not cause   Disease Susceptibility     Colorectal Neoplasms     insertion mutation in the BRCA1 gene does not cause increased occurrence of disease susceptibility associated with colorectal neoplasms    [1], E  
BRCA1   DNA   gene deletion mutation   may not cause   Disease Susceptibility     Colorectal Neoplasms     deletion mutation in the BRCA1 gene does not cause increased occurrence of disease susceptibility associated with colorectal neoplasms    [1], E  
BRCA1   DNA   gene mutation   may not correlate with   familial     Prostatic Neoplasms     mutation in the BRCA1 gene may not correlate with familial form of prostatic neoplasms    [3], E; [4], E  
BRCA1   DNA   maps to disease locus   does not correlate with   Genetic Predisposition to Disease     Prostatic Neoplasms     BRCA1 map position does not correlate with genetic predisposition to disease associated with prostatic neoplasms    [5], E  
BRCA1   DNA   gene mutation   does not correlate with   familial     Prostatic Neoplasms     mutation in the BRCA1 gene does not correlate with familial form of prostatic neoplasms    [6], E  
BRCA1   DNA   gene mutation   may not correlate with   early onset     Prostatic Neoplasms     mutation in the BRCA1 gene may not correlate with early onset form of prostatic neoplasms    [3], E  
References  [hide]
jump to top
   (6 entries)
[1] PMID 11207040. The frequency of the predominant Jewish mutations in BRCA1 and BRCA2 in unselected Ashkenazi colorectal cancer patients. British Journal Of Cancer 84(4) 475-7. (2001)
[2] PMID 11072248. Genetic analysis of a breast-ovarian cancer family, with 7 cases of colorectal cancer linked to BRCA1, fails to support a role for BRCA1 in colorectal tumorigenesis. International Journal Of Cancer 88(5) 778-82. (2000)
[3] PMID 10945492. The rate of the founder Jewish mutations in BRCA1 and BRCA2 in prostate cancer patients in Israel. British Journal Of Cancer 83(4) 463-6 (2000)
[4] PMID 10728701. BRCA1 and BRCA2 have a limited role in familial prostate cancer. Cancer Research 60(5) 1371-5 (2000)
[5] PMID 10398279. Common mutations in BRCA1 and BRCA2 do not contribute to early prostate cancer in Jewish men. Prostate 40(3) 172-7 (1999)
[more . . .]